The FDA granted an orphan drug designation for the novel drug, NT-17, to treat people with acute radiation syndrome. The Food and Drug Administration (FDA) has granted Orphan Drug Designation for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results